News

Pfizer (PFE) stock in focus as the company with Astellas Pharma (ALPMF) (ALPMY) announce a Phase 3 trial win for their ...
The hot flashes and night sweats that plague breast cancer survivors during years-long hormone-suppressing therapy are eased ...
Xtandi plus leuprolide improved overall survival in prostate cancer patients in the Phase 3 EMBARK trial, with no new safety ...
On the forefront of healthcare change, turning innovative science into value for patients: Astellas at ASCO 2025 At this year ...
Astellas Pharma Inc. recently created a new role — that of chief research & development officer — and named Cambridge ...
While the Japanese employee of Astellas Pharma was indicted in August last year, the Chinese side has not disclosed details ...
In July 2025, Novartis Pharmaceuticals conducted a Phase III multi-center, single dose (1.2 x 1014 vector genomes), ...
A European pharma trade organisation has said that a new strategy launched by the EU to bolster the region's standing in life ...
View today's Astellas Pharma Inc. stock price and latest 4503 news and analysis. Create real-time notifications to follow any changes in the live stock price.
Here is how Alpha Cognition Inc. (ACOG) and Astellas Pharma Inc. (ALPMY) have performed compared to their sector so far this year.
View the latest Astellas Pharma Inc. ADR (ALPMY) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Mitsubishi Research Institute, Inc. (MRI) and Astellas Pharma Inc. (Astellas), is a global life sciences company, announced that they have agreed on a memorandum of understanding to provide ...